Article
Inducible pluripotent stem cells: not quite ready for prime time?
13 Jan 2010
Abstract excerpt
PURPOSE OF REVIEW: Inducible pluripotent stem (iPS) cells derived from somatic cells represent a novel renewable source of tissue precursors. The potential of iPS cells is considered to be at least equivalent to that of human embryonic stem cells, facilitating the treatment or cure of diseases such as diabetes mellitus, spinal cord injuries, cardiovascular disease, and neurodegenerative diseases, but with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
